News & Stories for Oregonians
La Administración de Alimentos y Medicamentos de Estados Unidos anunció que Evusheld ya no está autorizado para uso de emergencia porque es posible que no proteja contra las subvariantes de COVID-19 que circulan actualmente en los Estados Unidos. Como resultado, no se puede utilizar en pacientes nuevos o en pacientes que lo habían recibido anteriormente […]
Available in Spanish The U.S. Food and Drug Administration has announced that, until further notice, Evusheld is no longer authorized for emergency use because it is not expected to protect against the COVID-19 subvariants currently circulating in the United States. As a result, it cannot be used for new patients or for patients who have […]
On Dec. 8, 2021, the Food and Drug Administration (FDA) authorized AstraZeneca’s Evusheld under emergency use for prevention of COVID-19 infection in certain adults and children. Evusheld is a long-acting monoclonal antibody therapy.
